BioSpace News Archive

ASEAN Biological Optical Microscope Market to Reach US$74.7 Mn by 2031, Increase in Funding for R&D in Biotechnology and Cell Biology to Drive the Market

According to the report, the biological optical microscope market in ASEAN was valued at US$ 46.8 Mn in 2020 and is projected to expand at a CAGR of 4.3% from 2021 to 2031.

April 28, 2022
·
5 min read
Drug Development

Diadem Announces Publication of Peer-Reviewed Article Describing How Post-Translational Modifications of p53 Variants May Contribute to Development of Alzheimer’s Disease

Diadem SpA announced release of a new peer-reviewed publication, Post-Translational Modifications of the p53 Protein and the Impact in Alzheimer’s Disease: A Review of the Literature, in the current issue of the journal Frontiers in Aging Neuroscience.

April 28, 2022
·
6 min read
Biovica Capital Markets Day Invitation May 17, 2022

Biovica is approaching market launch of DiviTum®TKa in the US for the monitoring of metastatic breast cancer treatments.

April 28, 2022
·
2 min read
Business

Orexo Interim Report Q1 2022

Christine Rankin and Michael J Matly were elected as Board members at the Annual General Meeting. They replace David Colpman and Kirsten Detrick who have declined re-election.

April 28, 2022
·
3 min read
Business

GC Biopharma Concludes Agreement With Acuitas Therapeutics for Lipid Nanoparticle Delivery System for Use in mRNA Vaccines and Therapeutics

GC Biopharma and Acuitas Therapeutics announced that they have entered into a Development and Option agreement for Acuitas’ LNP technology.

April 28, 2022
·
2 min read
Business

argenx to Report First Quarter 2022 Financial Results and Business Update on May 5, 2022

argenx announced that it will host a conference call and audio webcast on Thursday, May 5, 2022 at 2:30 pm CET to discuss its first quarter 2022 financial results and provide a business update.

April 28, 2022
·
1 min read
Business

Thermo Fisher Scientific Reports First Quarter 2022 Results

Thermo Fisher Scientific Inc., the world leader in serving science, reported its financial results for the first quarter ended April 2, 2022.

April 28, 2022
·
18 min read
Drug Development

Alzamend Neuro Announces $4 Million Additional Investment from Digital Power Lending Upon Completion of Phase 1 First-in-Human Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Alzamend Neuro, Inc. announced that Digital Power Lending, LLC, a wholly owned subsidiary of BitNile Holdings, Inc., a diversified holding company, has made an additional investment in the Company.

April 28, 2022
·
5 min read
Business

Merck Announces First-Quarter 2022 Financial Results

Merck, known as MSD outside the United States and Canada, announced financial results for the first quarter of 2022.

April 28, 2022
·
32 min read
Lytix Biopharma to present at the American Society of Clinical Oncology (ASCO) Annual Meeting

Lytix Biopharma AS (Lytix), a clinical-stage company with an in situ vaccination technology platform targeting cancer indications, today announces that its abstract has been accepted for poster presentation at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago June 3-7, 2022.

April 28, 2022
·
2 min read